362 related articles for article (PubMed ID: 10764686)
1. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.
Morange PE; Lijnen HR; Alessi MC; Kopp F; Collen D; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1150-4. PubMed ID: 10764686
[TBL] [Abstract][Full Text] [Related]
2. Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Morange PE; Bastelica D; Bonzi MF; Van Hoef B; Collen D; Juhan-Vague I; Lijnen HR
Thromb Haemost; 2002 Feb; 87(2):306-10. PubMed ID: 11858492
[TBL] [Abstract][Full Text] [Related]
3. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.
Lijnen HR; Maquoi E; Morange P; Voros G; Van Hoef B; Kopp F; Collen D; Juhan-Vague I; Alessi MC
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):78-84. PubMed ID: 12524228
[TBL] [Abstract][Full Text] [Related]
4. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.
Lijnen HR
Thromb Haemost; 2005 May; 93(5):816-9. PubMed ID: 15886793
[TBL] [Abstract][Full Text] [Related]
5. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.
De Taeye BM; Novitskaya T; Gleaves L; Covington JW; Vaughan DE
J Biol Chem; 2006 Oct; 281(43):32796-805. PubMed ID: 16931518
[TBL] [Abstract][Full Text] [Related]
7. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity.
Lijnen HR; Maquoi E; Demeulemeester D; Van Hoef B; Collen D
Thromb Haemost; 2002 Aug; 88(2):345-53. PubMed ID: 12195710
[TBL] [Abstract][Full Text] [Related]
8. Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1.
Semeraro F; Voros G; Collen D; Lijnen HR
Thromb Haemost; 2006 Jan; 95(1):174-81. PubMed ID: 16543977
[TBL] [Abstract][Full Text] [Related]
9. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
10. Tiplaxtinin impairs nutritionally induced obesity in mice.
Lijnen HR; Alessi MC; Frederix L; Collen D; Juhan-Vague I
Thromb Haemost; 2006 Dec; 96(6):731-7. PubMed ID: 17139366
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl/6 mice: modulation by diet-induced obesity.
Bartelt A; Beil FT; Schinke T; Roeser K; Ruether W; Heeren J; Niemeier A
Bone; 2010 Oct; 47(4):736-45. PubMed ID: 20633710
[TBL] [Abstract][Full Text] [Related]
12. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.
Ma LJ; Mao SL; Taylor KL; Kanjanabuch T; Guan Y; Zhang Y; Brown NJ; Swift LL; McGuinness OP; Wasserman DH; Vaughan DE; Fogo AB
Diabetes; 2004 Feb; 53(2):336-46. PubMed ID: 14747283
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice.
Lijnen HR; Demeulemeester D; Van Hoef B; Collen D; Maquoi E
Thromb Haemost; 2003 Feb; 89(2):249-55. PubMed ID: 12574803
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H
Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development.
Lijnen HR; Frederix L; Scroyen I
J Thromb Haemost; 2007 Nov; 5(11):2259-65. PubMed ID: 17958744
[TBL] [Abstract][Full Text] [Related]
16. On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice.
Lijnen HR; Alessi MC; Van Hoef B; Collen D; Juhan-Vague I
J Thromb Haemost; 2005 Jun; 3(6):1174-9. PubMed ID: 15946208
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity.
Lijnen HR; Van HB; Frederix L; Rio MC; Collen D
Thromb Haemost; 2002 Mar; 87(3):530-5. PubMed ID: 11916087
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
20. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
Sudi KM; Gallistl S; Tröbinger M; Payerl D; Weinhandl G; Muntean W; Aigner R; Borkenstein MH
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
